Hisham Bin Saad Al-Jadhey – CEO, Saudi Food and Drug Authority (SFDA)

Speaking exclusively to PharmaBoardroom, Prof. Hisham Bin Saad Al-Jadhey, CEO of the Saudi Food and Drug Authority (SFDA), outlines the SFDA's key priorities under its current strategic plan. He also touches on why domestic pharma and medtech manufacturing is important to the SFDA, pricing issues for innovative new therapies, and the role of the Authority within the Saudi 'Vision 2030' plan.  
SFDA has been developing very fast over the past couple of years and our future is even more promising. We are improving our regulations and processes to protect our citizens and to bring more investments to Saudi Arabia
Become a PharmaBoardroom Member for free to access this content
Join the 35,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report